(Total Views: 116)
Posted On: 07/06/2021 4:25:50 PM
Post# of 15415
$SEEL News Article - Seelos Therapeutics Doses First Patient in Part 2 of a Registrational Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder https://marketwirenews.com/news-releases/seel...43213.html
(0)
(0)
My Twitter: WhyteStocks
